Article
Low prevalence and variable clinical presentation of troponin I and troponin T gene mutations in hypertrophic cardiomyopathy.
Genetic testing and molecular biomarkers - 1 Oct 2009
Curila Karol, Benesova Lucie, Penicka Martin, Minarik Marek, Zemanek David, Veselka Josef, Widimsky Petr, Gregor Pavel
Abstract excerpt
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant disorder caused by mutations in cardiac sarcomeric proteins. Troponin I (TNNI3) and troponin T (TNNT2) are important parts of the sarcomere in heart muscle, and mutations in their genes are responsible for development of HCM. The prevalence of mutations in these two genes is low; hence, the data on clinical outcome are scarce. Yet, some of these mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
